Stifel Nicolaus Initiates Coverage on Tempus AI (NASDAQ:TEM)

Stifel Nicolaus began coverage on shares of Tempus AI (NASDAQ:TEM) in a report released on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $45.00 price objective on the stock.

Other analysts have also issued research reports about the company. Needham & Company LLC began coverage on Tempus AI in a research note on Tuesday. They set a buy rating and a $47.00 price objective on the stock. TD Cowen assumed coverage on Tempus AI in a research report on Tuesday. They set a buy rating and a $50.00 target price on the stock. JPMorgan Chase & Co. assumed coverage on Tempus AI in a research report on Tuesday. They set an overweight rating and a $42.00 target price on the stock. Finally, Loop Capital assumed coverage on Tempus AI in a research report on Tuesday. They set a buy rating and a $48.00 target price on the stock. Nine research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of Buy and a consensus target price of $45.63.

Tempus AI Price Performance

TEM opened at $37.50 on Tuesday. Tempus AI has a 52 week low of $22.89 and a 52 week high of $43.88.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.